Clin2
NCT07106125Possibly a fitNot yet recruiting

Extended antibiotics after kidney transplant

Kidney TransplantUrinary Tract Infection(UTI)Antibiotic ProphylaxisRemote Patient MonitoringFeasibility Pilot Study

Treatments studied

Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at whether continuing an antibiotic called TMP-SMX (Bactrim) for longer helps prevent urinary tract infections after a kidney transplant. If you've already taken it safely for 6 months, you may qualify to continue it for another 6 months or stop, to see which is better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
12 years to 29 years
Study type
Interventional

Who can take part

  • Had a kidney transplant at UCSF within the last 6 months
  • Can take capsules by mouth
  • Kidney function is good enough (GFR greater than 30)
  • You were able to take TMP-SMX (Bactrim) for the first 6 months after surgery without stopping
  • No allergy to TMP-SMX or sulfa drugs
  • No recent urinary tract infection resistant to TMP-SMX

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07407673Not yet recruiting· Phase 3
Preventing blood infections after kidney transplant

This study tests whether giving an antibiotic after a kidney transplant can prevent bloodstream infections. Participants who have bacteria in their urine in the first month after transplant may be eligible.

Aarhus
NCT06802822Not yet recruiting
Continuing anti-rejection medicine after a failed kidney transplant

This study tests whether continuing certain anti-rejection medicines while on dialysis can help lower the risk of your immune system becoming too sensitive to a future kidney transplant. It might help you stay eligible for another transplant later.

Vancouver, British Columbia
NCT07224997Not yet recruiting· Phase 2
Antibiotic to prevent infections after acute kidney injury

This trial tests a preventive antibiotic (a combination of two drugs) to see if it can reduce the chance of infections after leaving the hospital in people who had acute kidney injury (sudden kidney failure) during their stay. It is intended for people who are recovering and about to go home or to a rehabilitation facility.

NCT07765615Not yet recruiting
Personalized antibiotic dosing after kidney transplant

This study looks at giving anti-infection medications (antibiotics) in a more personalized way soon after a kidney transplant. By carefully adjusting the dose, doctors hope to prevent infections while keeping the new kidney safe.

NCT05597540Recruiting· Phase 3
Shorter antibiotics for kidney transplant kidney infections

This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.

Bordeaux
NCT07619027Not yet recruiting· Phase 4
Comparing lower vs standard dose of an antibiotic to prevent lung infection after kidney transplant

This study compares a lower dose versus the standard dose of the antibiotic TMP-SMX (Bactrim) to prevent a type of lung infection (Pneumocystis pneumonia) after a kidney transplant. If you are eligible, you will receive either a lower or standard dose to see which works just as well with fewer side effects.

Hear when a new Kidney Transplant trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.